December 24, 2018
During this challenging time in healthcare news, our pharma outlook aims to help investors steer through the industry.
October 31, 2018
Acorda Therapeutics (Nasdaq:ACOR) provided a financial and pipeline update for the third quarter ended September 30, 2018. As quoted in...
January 30, 2017
Donald Trump's immigration ban has sparked outrage around the world, and biotech executives are speaking out.
November 24, 2016
With January fast approaching, it’s worthwhile to reexamine Trump’s stance on various industry-related questions.
November 21, 2016
Acorda Therapeutics has announced that results from its MILESTONE clinical study did not support continued development of dalfampridine as a...
June 13, 2016
TURKU, Finland–(BUSINESS WIRE)–Biotie Therapies Corp. (Nasdaq Helsinki: BTH1V) (“Biotie” or the “Company”) announces that the voluntary delisting of its American...
May 18, 2016
TURKU, Finland–(BUSINESS WIRE)–Biotie Therapies Corp. (“Biotie”) today announces that its Board of Directors has resolved to voluntarily delist its American...